FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors ...
San Carlos-based doctor, Dr. Haleh Sheikholeslami, who was scheduled for a two-week humanitarian trip to Gaza is finally returning to the Bay Area four weeks after arriving in the war-torn region.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback